A rating of 90 puts ProQR Therapeutics NV (PRQR) near the top of the Biotechnology industry according to InvestorsObserver. ProQR Therapeutics NV's score of 90 means it scores higher than 90% of stocks in the industry. ProQR Therapeutics NV also received an overall rating of 70, putting it above 70% of all stocks. Biotechnology is ranked 47 out of the 148 industries.
PRQR has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on PRQR!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With ProQR Therapeutics NV Stock Today?
ProQR Therapeutics NV (PRQR) stock is higher by 5.33% while the S&P 500 has fallen -0.29% as of 10:44 AM on Tuesday, Aug 1. PRQR is up $0.08 from the previous closing price of $1.50 on volume of 211,838 shares. Over the past year the S&P 500 has gained 11.09% while PRQR is up 90.36%. PRQR lost -$0.90 per share the over the last 12 months.
Click Here to get the full Stock Report for ProQR Therapeutics NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
